Open App
Company / Named in our posts

Acrivon Therapeutics, Inc..

Follow Acrivon Therapeutics, Inc.

A clinical-stage biotechnology company discovering and developing precision medicines using its proprietary Generative AI-driven Phosphoproteomics AP3 platform for rational drug design and predictive clinical development.[1]

01Deal
01

Deals on Carrywatch

Every deal that names Acrivon Therapeutics, Inc., and its role in each.

Acrivon Therapeutics, Inc. / Aqilion AB

Acrivon Therapeutics expands into immunology with Aqilion programs

See deal details
02

Deal Web

Acrivon Therapeutics, Inc. and 0 firms it shares a posted deal with, and the path to any other firm.

03

News

Loading headlines.

04

Sources

As of 6 Nov 2026.

  1. 01
    Exhibit 99.1

    U.S. Securities and Exchange Commission · Researched 6 Nov 2026

  2. 02
    Form 8-K

    U.S. Securities and Exchange Commission · Researched 6 Nov 2026

Deal posts naming Acrivon Therapeutics, Inc.:

  1. P01